Page last updated: 2024-09-03

y 27632 and Triple Negative Breast Neoplasms

y 27632 has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jones, BC; Kelley, LC; Kozyreva, VK; Loskutov, YV; Marinak, KM; Pugacheva, EN; Smolkin, MB	1

Other Studies

1 other study(ies) available for y 27632 and Triple Negative Breast Neoplasms

Article	Year
Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior. Molecular cancer research : MCR, 2017, Volume: 15, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Amides; Animals; Aurora Kinase A; Azepines; Cell Line, Tumor; Cell Movement; Cortactin; Enzyme Inhibitors; Female; Humans; Mice, Inbred NOD; Molecular Targeted Therapy; Myosin Light Chains; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-vav; Pyridines; Pyrimidines; rac1 GTP-Binding Protein; rho-Associated Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2017

Article

Year

Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.

Molecular cancer research : MCR, 2017, Volume: 15, Issue:6

Topics: Adaptor Proteins, Signal Transducing; Amides; Animals; Aurora Kinase A; Azepines; Cell Line, Tumor; Cell Movement; Cortactin; Enzyme Inhibitors; Female; Humans; Mice, Inbred NOD; Molecular Targeted Therapy; Myosin Light Chains; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-vav; Pyridines; Pyrimidines; rac1 GTP-Binding Protein; rho-Associated Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2017